Reports
Sale
North America Intracranial Aneurysm Market Size, Analysis: By Treatment Type: Surgical Clipping, Endovascular Coiling, Flow Diverters, Others; By End-Use: Hospitals, Clinics, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Demand Indicators, Key Price Indicators; Supplier Landscape; 2024-2032
North America Intracranial Aneurysm Market Outlook
The North America intracranial aneurysm market size is expected to grow at a CAGR of 21.07% during the forecast period of 2024-2032, driven by the growing prevalence of intracranial aneurysms and the rise in technological innovations in treatment devices in the region.
Key Takeaways
- Around 6.8 million people have an unruptured intracranial aneurysm in the United States, with the rate of rupture estimated to be 8-10 per every 100,000 individuals annually. This rising prevalence is expected to impact market demand.
- The development of new treatment options with higher success rates and better safety profiles is likely to augment the North America intracranial aneurysm market share in coming years. In December 2023, Galaxy Therapeutics’ Endovascular Aneurysm Lattice (SEAL) embolization system, showed a 100% technical success rate, 76.9% rate of progressive complete occlusion, and 0% retreatment rate in the PRE-SEAL IT trial.
- In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., gaining access to Cerus Endovascular's Contour Neurovascular System and Neqstent Coil Assisted Flow Diverter, thereby strengthening its existing portfolio of aneurysm treatment solutions. Such strategic partnerships are expected to elevate market value in the region.
North America Intracranial Aneurysm Market Analysis
Intracranial aneurysm, also known as brain aneurysm or cerebral aneurysm is a condition characterized by ballooning or bulging in a blood vessel in the brain. Rupturing or leaking of the aneurysm can cause bleeding in the brain called hemorrhagic stroke. A ruptured aneurysm can be life-threatening and requires immediate treatment. Advancements in endovascular techniques, including improvements in device technology and materials used for endovascular coiling and flow diversion are expected to significantly impact North America intracranial aneurysm market demand. In addition, the rising patient inclination towards minimally invasive procedures owing to the associated benefits such as fewer complications and reduced recovery time are poised to influence the market dynamics.
The market is experiencing a surge in the demand for intracranial aneurysm treatments which can be attributed to the increased prevalence of the condition in North America. Recent data suggests that around 6.8 million people have an unruptured intracranial aneurysm in the United States, with the rate of rupture estimated to be 8-10 per every 100,000 individuals annually. With around 30,000 people suffering from an intracranial aneurysm rupture every year in the region, the market size is likely to expand in the coming years.
The key players in the market are actively investing in developing new treatment options for intracranial aneurysms with higher success rates and better safety profiles, thereby contributing to the North America intracranial aneurysm market growth. In December 2023, data revealed at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference demonstrated positive results for a device abelled “the third way” developed by Galaxy Therapeutics (a United States-based, clinical-stage medical device company). It is developed to treat intracranial aneurysms using an intrasaccular approach. The one-year results of a first-in-human study, the PRE-SEAL IT trial which evaluated the efficacy of the novel Saccular Endovascular Aneurysm Lattice (SEAL) embolization system, showed a 100% technical success rate, 76.9% rate of progressive complete occlusion at 1 year and 0% retreatment rate. Thus, the SEAL device exhibited effectiveness as well as a good safety profile across a range of challenging aneurysms. The development of such innovative devices is anticipated to propel the market growth in the forecast period.
One of the significant North America intracranial aneurysm market trends is the increased merger and acquisition initiatives among the leading market players. In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a United States-based medical technology company specializing in interventional neuroradiology devices for the treatment of intracranial aneurysms. Under this acquisition, the company will get access to Cerus Endovascular's CE Marked products, the Contour Neurovascular System as well as the Neqstent Coil Assisted Flow Diverter, strengthening Stryker’s existing portfolio of aneurysm treatment solutions. Such strategic partnerships are expected to foster better access to intracranial aneurysm treatments and are expected to elevate market value in the region.
North America Intracranial Aneurysm Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Treatment Type | Surgical Clipping, Endovascular Coiling, Flow Diverters, Others |
| End-Use | Hospitals, Clinics, Others |
| Countries | United States of America, Canada |
North America Intracranial Aneurysm Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Stryker
- B. Braun Melsungen AG
- MicroPort Scientific Corporation
- Medtronic
- Johnson & Johnson
- Codman Neuro (Integra Lifesciences)
- Raumedic AG
- Delta Surgical
- Penumbra, Inc.
- Mizuho Medical Co. Ltd.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End-Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Intracranial Aneurysm Market Overview
3.1 North America Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 North America Intracranial Aneurysm Market Forecast Value (2024-2032)
4 North America Intracranial Aneurysm Market Landscape*
4.1 North America Intracranial Aneurysm Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Intracranial Aneurysm Market: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 North America Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 North America Intracranial Aneurysm Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Surgical Clipping
6.1.3 Endovascular Coiling
6.1.4 Flow Diverters
6.1.5 Others
6.2 North America Intracranial Aneurysm Market (2017-2032) by End-Use
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Others
6.3 North America Intracranial Aneurysm Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 United States of America
6.3.3 Canada
7 United States of America Intracranial Aneurysm Market (2017-2032)
7.1 United State of America Intracranial Aneurysm Market (2017-2032) by Treatment Type
7.1.1 Market Overview
7.1.2 Surgical Clipping
7.1.3 Endovascular Coiling
7.1.4 Flow Diverters
7.1.5 Others
7.2 United State of America Intracranial Aneurysm Market (2017-2032) by End-Use
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Clinics
7.2.4 Others
8 Canada Intracranial Aneurysm Market (2017-2032)
8.1 Canada Intracranial Aneurysm Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Surgical Clipping
8.1.3 Endovascular Coiling
8.1.4 Flow Diverters
8.1.5 Others
8.2 Canada Intracranial Aneurysm Market (2017-2032) by End-Use
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Clinics
8.2.4 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Stryker
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 B. Braun Melsungen AG
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 MicroPort Scientific Corporation
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Medtronic
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Johnson & Johnson
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Codman Neuro (Integra Lifesciences)
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Raumedic AG
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Delta Surgical
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Penumbra, Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Mizuho Medical Co.Ltd.
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 North America Intracranial Aneurysm Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 21.07% during the forecast period of 2024-2032, driven by the growing prevalence of intracranial aneurysms in the region.
The rising patient inclination towards minimally invasive procedures and increasing healthcare investments are fuelling the market demand.
One of the significant trends in the market is the increased merger and acquisition initiatives among the leading market players. In May 2023, Stryker Corporation acquired Cerus Endovascular Ltd., strengthening its existing portfolio of aneurysm treatment solutions.
Based on the treatment type, the market is segmented into surgical clipping, endovascular coiling, and flow diverters, among others.
By end user, the market is divided into hospitals, and clinics, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Stryker, B. Braun Melsungen AG, MicroPort Scientific Corporation, Medtronic, Johnson & Johnson, Codman Neuro (Integra Lifesciences), Raumedic AG, Delta Surgical, Penumbra, Inc., and Mizuho Medical Co. Ltd.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER